Autoantibodies as potential biomarkers of high grade immune-related adverse events (irAEs) in metastatic melanoma patients treated with check point inhibitors (ICIs)

A. Gandhi, J. Taylor, M. Morici, A. Reid, T. Meniawy, M. A. Khattak, M. Millward, E. S. Gray, P. Zaenker

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

Original languageEnglish
Pages (from-to)S597-S597
Number of pages1
JournalAnnals of Oncology
Issue number7
Publication statusPublished - Sept 2022
Event2022 Annual Meeting of the European-Society-for-Medical-Oncology - , France
Duration: 9 Sept 202213 Sept 2022

Cite this